4R-tau strain-specific spreading patterns in PSP vs CBD — SciDEX Notebook
4R-tau strain-specific spreading patterns in PSP vs CBD
Analysis ID: SDA-2026-04-01-gap-005
Generated: 2026-04-02 | Platform: SciDEX | Layer: Agora + Forge
---
import numpy as np
import matplotlib.pyplot as plt
from scipy import stats
import warnings
warnings.filterwarnings('ignore')
print('Environment ready.')
Environment ready.
1. Hypothesis Ranking
The multi-agent debate generated 7 hypotheses, scored across 10 dimensions.
| Rank | Hypothesis | Target Gene | Score |
| 1 | Aquaporin-4 Polarization Rescue | AQP4 | 0.464 |
| 2 | Microglial Purinergic Reprogramming | P2RY12 | 0.463 |
| 3 | Complement C1q Subtype Switching | C1QA | 0.425 |
| 4 | Sphingolipid Metabolism Reprogramming | CERS2 | 0.423 |
| 5 | Glial Glycocalyx Remodeling Therapy | HSPG2 | 0.395 |
| 6 | Ephrin-B2/EphB4 Axis Manipulation | EPHB4 | 0.379 |
| 7 | Netrin-1 Gradient Restoration | NTN1 | 0.307 |
# Hypothesis composite scores bar chart
plt.show()
3. Multi-Dimensional Score Radar
Radar plot comparing top hypotheses across all 10 scoring dimensions.
# Multi-dimensional scoring radar
plt.show()
4. Differential Gene Expression Analysis
Simulated expression analysis for 7 target genes comparing disease vs. control.
# Volcano plot: Differential expression
plt.show()
5. Pathway Enrichment Analysis
Enrichment analysis identifies biological pathways overrepresented among target genes.
# Pathway enrichment bar chart
plt.show()
6. Statistical Analysis
Comprehensive statistical testing of hypothesis scores.
# Statistical summary
from scipy import stats
print(summary)
============================================================
STATISTICAL SUMMARY
============================================================
Hypotheses: 7
Composite — Mean: 0.4078, Median: 0.4226, Std: 0.0507, Range: [0.3067, 0.4639]
Novelty — Mean: 0.7786, Std: 0.0846
Feasibility — Mean: 0.5457, Std: 0.1729
Novelty-Feasibility Pearson r=-0.6186 (p=0.1387) Not significant
============================================================
Unknown
Novel Therapeutic Hypotheses for 4R-Tau Strain-Specific Spreading in PSP vs CBD
1. Glial Glycocalyx Remodeling Therapy
Description: PSP and CBD tau strains differentially interact with region-specific glial glycocalyx compositions, determining astrocytic morphology. Enzymatic remodeling of heparan sulfate proteoglycans could redirect pathological tau from forming tufted astrocytes (PSP) to less toxic configurations.
Target: HSPG2 (perlecan), EXT1/EXT2 (heparan sulfate biosynthesis...
Unknown
I'll provide a rigorous critique of each hypothesis, examining the evidence gaps and methodological concerns.
Critical Evaluation of Tau Strain-Specific Therapeutic Hypotheses
1. Glial Glycocalyx Remodeling Therapy
Specific Weaknesses:
The cited evidence (PMID: 31064851, 28334866) addresses general tau-HSPG interactions, not strain-specific differences between PSP and CBD tau
No direct evidence that heparan sulfate binding differences translate to therapeutic efficacy
Assumes c...
Unknown
Druggability Assessment of Tau Strain-Specific Therapeutic Hypotheses
1. Glial Glycocalyx Remodeling Therapy
Druggability: MODERATE
HSPG2/EXT1/EXT2: Limited druggability. EXT1/EXT2 are intracellular enzymes requiring small molecule penetration
Chemical matter: Heparanase inhibitors exist (SST0001, necuparanib) but are non-selectiveExisting compounds:
SST0001 (roneparstat): Phase II trials for multiple myeloma (NCT02194985)
Necuparanib: Phase I/II for panc...
Unknown
```json
{
"ranked_hypotheses": [
{
"title": "Microglial Purinergic Reprogramming",
"description": "P2Y12 receptor expression levels determine whether microglia promote tufted astrocyte formation (low P2Y12) versus astrocytic plaques (high P2Y12) by controlling ATP-mediated tau propagation signals. Selective P2Y12 modulation could redirect pathology.",
"target_gene": "P2RY12",
"dimension_scores": {
"mechanistic_plausibility": 0.7,
"evidence_strength":...
8. Key Citations
This analysis cited 20 papers:
PMID: 32160082 - The P2RY12 receptor promotes VSMC-derived foam cell formation by inhibiting auto (Autophagy, 2021)
PMID: 34571885 - Beyond Activation: Characterizing Microglial Functional Phenotypes. (Cells, 2021)
PMID: 41814722 - [Advantageous therapeutic pathways and mechanisms of Jianpi Huogu Formula in tre (Zhongguo Zhong Yao Za Zhi, 2026)
PMID: 41825304 - P2 purinergic receptors in systemic lupus erythematosus: from experimental findi (Curr Opin Immunol, 2026)
PMID: 41843422 - Differences in mRNA expression of neuroinflammation-related genes in the tempora (Epileptic Disord, 2026)
PMID: 41898413 - Clopidogrel Administration Impairs Neurovascular Unit Recovery and Exacerbates A (Int J Mol Sci, 2026)
PMID: 41924777 - Constitutive expression of CX3CR1-BAC-Cre introduces minimal off-target effects (Biochem Biophys Res Commun, 2026)
PMID: 35847503 - Disruption of adipocyte HIF-1α improves atherosclerosis through the inhibition o (Acta Pharm Sin B, 2022)
PMID: 38383790 - IL-10 constrains sphingolipid metabolism to limit inflammation. (Nature, 2024)
PMID: 38961186 - PAQR4 regulates adipocyte function and systemic metabolic health by mediating ce (Nat Metab, 2024)
PMID: 39792658 - Reduced circulating sphingolipids and CERS2 activity are linked to T2D risk and (Sci Adv, 2025)
PMID: 40624017 - EMP1 safeguards hematopoietic stem cells by suppressing sphingolipid metabolism (Nat Commun, 2025)
PMID: 18164103 - Interactions between the products of the Herpes simplex genome and Alzheimer's d (Neurochem Int, 2008)
PMID: 34433968 - APRIL limits atherosclerosis by binding to heparan sulfate proteoglycans. (Nature, 2021)
PMID: 37582915 - Spatial transcriptomics reveal markers of histopathological changes in Duchenne (Nat Commun, 2023)
---
Generated: 2026-04-02 | Platform: SciDEX | Layer: Agora + Forge
This notebook was auto-generated from the SciDEX multi-agent debate pipeline.
Generated by SciDEX — scidex.ai